Lijnen P, Hespel P, Fagard R, Staessen J, Goossens W, Lissens W, Amery A
Department of Pathophysiology, University Hospital Gasthuisberg, University of Leuven, Belgium.
J Hypertens. 1988 Aug;6(8):639-45. doi: 10.1097/00004872-198808000-00007.
The effect of xipamide on the intracellular concentration and transmembrane fluxes of Na+ and K+ was studied in 12 normal male subjects, using a double-blind cross-over design. After a run-in period on placebo for 1 week, the subjects were treated with either placebo (n = 6) or xipamide 20 mg once a day (n = 6) for 16 weeks and were then switched to the alternative medication for another 16 weeks. The intra-erythrocyte and intra-leucocyte Na+ concentration was increased by 11 and 7%, respectively, during xipamide administration, while the intracellular K+ concentration was decreased by 3 and 4%, respectively. No significant effect of xipamide could however be demonstrated on the ouabain-sensitive, bumetanide-sensitive or ouabain-bumetanide-resistant 86Rb uptake and on the maximal 3H-ouabain binding in erythrocytes and leucocytes. The red cell Na+-Li+ countertransport was also not changed in the xipamide-treated subjects. Our data suggest that the increased intracellular Na+ concentration and the decreased K+ concentration in red and white blood cells of xipamide-treated subjects cannot be attributed to changes in the activity of the Na+ pump, the Na+-K+ cotransport or Na+-Li+ countertransport system or to changes in the number of active Na+ pump units.
采用双盲交叉设计,在12名正常男性受试者中研究了氯噻嗪对细胞内Na⁺和K⁺浓度及跨膜通量的影响。在服用安慰剂1周的导入期后,受试者接受安慰剂(n = 6)或氯噻嗪20 mg每日一次(n = 6)治疗16周,然后换用另一种药物再治疗16周。在服用氯噻嗪期间,红细胞内和白细胞内的Na⁺浓度分别升高了11%和7%,而细胞内K⁺浓度分别降低了3%和4%。然而,未发现氯噻嗪对红细胞和白细胞中哇巴因敏感、布美他尼敏感或哇巴因-布美他尼抵抗的⁸⁶Rb摄取以及最大³H-哇巴因结合有显著影响。在接受氯噻嗪治疗的受试者中,红细胞Na⁺-Li⁺逆向转运也未改变。我们的数据表明,氯噻嗪治疗受试者的红细胞和白细胞中细胞内Na⁺浓度升高和K⁺浓度降低,不能归因于Na⁺泵活性、Na⁺-K⁺协同转运或Na⁺-Li⁺逆向转运系统的变化,也不能归因于活性Na⁺泵单位数量的变化。